iodixanol has been researched along with Kidney Diseases in 97 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this clinical trial is to compare iodixanol with iohexol for the incidence of contrast-induced nephropathy in patients with chronic heart failure with reduced ejection fraction who are currently undergoing coronary angiography or angioplasty." | 9.24 | Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty. ( Ge, Z; Li, Y; Shi, P; Song, M; Song, T; Sun, M, 2017) |
| "In order to compare the effects of iopromide and isoxazole on postoperative contrast-induced nephropathy in patients with renal insufficiency, the paper searches for randomized controlled trials and retrospective cohort studies comparing the effects of iopromide and iodixanol on renal function in patients with renal insufficiency after surgery." | 9.22 | Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis. ( Duan, Z; Feng, Y; Hu, W; Li, P; Qiu, G; Wang, L; Wang, M; Xu, C; Zhou, H, 2022) |
| " The objective of our meta-analysis was to compare the clinical safety of iso-osmolar contrast medium iodixanol to low-osmolar contrast medium iopromide in patients with renal insufficiency undergoing coronary angiography with or without percutaneous coronary intervention (PCI)." | 8.98 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. ( Chen, M; Jiang, Y; Rui, Q; Yang, H; Zhang, J; Zhang, N; Zhou, Y, 2018) |
| "The combined prophylactic strategy of sodium bicarbonate plus N-acetylsyteine (NAC) seems to be effective in preventing contrast induced acute kidney injury (CI-AKI) in patients at low-to-medium risk." | 6.25 | Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. ( Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G, 2011) |
| "The aim of this clinical trial is to compare iodixanol with iohexol for the incidence of contrast-induced nephropathy in patients with chronic heart failure with reduced ejection fraction who are currently undergoing coronary angiography or angioplasty." | 5.24 | Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty. ( Ge, Z; Li, Y; Shi, P; Song, M; Song, T; Sun, M, 2017) |
| "In order to compare the effects of iopromide and isoxazole on postoperative contrast-induced nephropathy in patients with renal insufficiency, the paper searches for randomized controlled trials and retrospective cohort studies comparing the effects of iopromide and iodixanol on renal function in patients with renal insufficiency after surgery." | 5.22 | Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis. ( Duan, Z; Feng, Y; Hu, W; Li, P; Qiu, G; Wang, L; Wang, M; Xu, C; Zhou, H, 2022) |
| " In 562 evaluable patients (of 592 recruited), the contrast volume, presence of diabetes mellitus, mean baseline SCr and estimated glomerular filtration rate (eGFR) were comparable between the iopromide- and iodixanol-treated groups." | 5.16 | Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. ( Chen, Y; Fu, G; Gao, C; Gao, W; He, B; He, Q; Hu, S; Liu, H; Liu, S; Liu, Y; Qi, X; Qiu, C; Su, X; Wang, J; Wang, L; Wang, M; Yang, P; Zhao, R; Zheng, X; Zheng, Y; Zhou, S, 2012) |
| " The objective of our meta-analysis was to compare the clinical safety of iso-osmolar contrast medium iodixanol to low-osmolar contrast medium iopromide in patients with renal insufficiency undergoing coronary angiography with or without percutaneous coronary intervention (PCI)." | 4.98 | Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI. ( Chen, M; Jiang, Y; Rui, Q; Yang, H; Zhang, J; Zhang, N; Zhou, Y, 2018) |
| "Hyperhomocysteinemia induces oxidative stress and endothelial dysfunction, which share the proposed pathophysiologic mechanisms of contrast-induced nephropathy (CIN)." | 3.77 | Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. ( Choi, D; Choi, KH; Han, SH; Hong, MK; Jang, Y; Kang, SW; Kim, BK; Kim, JS; Kim, SJ; Ko, YG; Yoo, TH, 2011) |
| "Iodixanol was cost-effective compared with iohexol, with both lower costs and better effects related to fewer adverse drug reactions." | 2.71 | Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. ( Aspelin, P; Aubry, P; Fransson, SG; Lundkvist, J; Strasser, R; Willenbrock, R, 2005) |
| " This contrast agent has the lowest rates of systemic and renal adverse events." | 2.43 | Renal safety of iodixanol. ( McCullough, PA, 2006) |
| "Iodixanol, showed a lower CI-AKI incidence than low-osmolar contrast media (LOCM)." | 1.40 | Economic evaluation of intravenous iodinated contrast media in Italy. ( De Francesco, M; Iannazzo, S; Morana, G; Nayak, A; Ronco, C; Valentino, M; Vandekerckhove, S, 2014) |
| "The incidence of CIN in patients with multiple myeloma with a normal creatinine level is low and correlates with β(2)-microglobulin levels." | 1.37 | Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. ( Avigan, DE; Kruskal, JB; LeBedis, CA; Pahade, JK; Pedrosa, I; Raptopoulos, VD; Yam, CS, 2011) |
| "Iodixanol was administered intravenously at 10-40 mg I/kg to geldings and mares, and blood was collected 30, 60, 90, 120, 150, and 180 min later." | 1.37 | Optimum conditions for serum clearance of iodixanol, applicable to the estimation of glomerular filtration rate in horses. ( Abe, S; Furuhama, K; Kato, M; Saito, J; Satoh, H, 2011) |
| " Moreover, iodixanol decreased NO bioavailability by more than 82%." | 1.35 | Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. ( Cao, C; Pallone, TL; Patzak, A; Persson, AE; Persson, PB; Sendeski, M, 2009) |
| " Accumulating evidence suggests that the use of iso-osmolar contrast agents in conjunction with other proven measures, especially adequate intravenous hydration and contrast dosage limitation, can reduce the morbidity and mortality associated with CIN." | 1.32 | Recent clinical trials of iodixanol. ( Davidson, CJ; Erdogan, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (2.06) | 18.2507 |
| 2000's | 55 (56.70) | 29.6817 |
| 2010's | 38 (39.18) | 24.3611 |
| 2020's | 2 (2.06) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y | 1 |
| Qiu, G | 1 |
| Xu, C | 1 |
| Duan, Z | 1 |
| Wang, M | 2 |
| Wang, L | 2 |
| Hu, W | 1 |
| Li, P | 1 |
| Zhou, H | 1 |
| Freitas, RAP | 1 |
| Tanajura, LF | 1 |
| Mehran, R | 2 |
| Chamié, D | 1 |
| Chaves, A | 1 |
| Centemero, M | 1 |
| Braga, S | 1 |
| Costa, R | 1 |
| Cao, D | 1 |
| Sousa, A | 1 |
| Feres, F | 1 |
| Costa, JR | 1 |
| Song, T | 1 |
| Song, M | 1 |
| Ge, Z | 1 |
| Li, Y | 1 |
| Shi, P | 1 |
| Sun, M | 1 |
| Terrenato, I | 1 |
| Sperati, F | 1 |
| Musicco, F | 1 |
| Pozzi, AF | 1 |
| di Turi, A | 1 |
| Caterino, M | 1 |
| de Lutio di Castelguidone, E | 1 |
| Setola, SV | 1 |
| Bellomi, M | 1 |
| Neumaier, CE | 1 |
| Conti, L | 1 |
| Cigliana, G | 1 |
| Merola, R | 1 |
| Antenucci, A | 1 |
| Orlandi, G | 1 |
| Giordano, A | 1 |
| Barba, M | 1 |
| Canitano, S | 1 |
| Arokiaraj, MC | 1 |
| Menesson, E | 1 |
| Feltin, N | 1 |
| Han, XF | 1 |
| Zhang, XX | 1 |
| Liu, KM | 1 |
| Tan, H | 1 |
| Zhang, Q | 1 |
| Zhang, J | 1 |
| Jiang, Y | 1 |
| Rui, Q | 1 |
| Chen, M | 1 |
| Zhang, N | 1 |
| Yang, H | 1 |
| Zhou, Y | 2 |
| Wang, Y | 1 |
| Zhao, HW | 1 |
| Zhang, XJ | 1 |
| Chen, BJ | 1 |
| Yu, GN | 1 |
| Hou, AJ | 1 |
| Luan, B | 1 |
| Becker, J | 1 |
| Babb, J | 1 |
| Serrano, M | 1 |
| Iannazzo, S | 1 |
| Vandekerckhove, S | 1 |
| De Francesco, M | 1 |
| Nayak, A | 1 |
| Ronco, C | 1 |
| Morana, G | 2 |
| Valentino, M | 1 |
| Li, LP | 2 |
| Lu, J | 1 |
| Franklin, T | 2 |
| Solomon, R | 4 |
| Prasad, PV | 2 |
| Jurado-Román, A | 1 |
| Hernández-Hernández, F | 1 |
| García-Tejada, J | 2 |
| Granda-Nistal, C | 1 |
| Molina, J | 1 |
| Velázquez, M | 2 |
| Albarrán, A | 2 |
| Tascón, J | 2 |
| Sasaki, Y | 1 |
| Iwama, R | 1 |
| Shimamura, S | 1 |
| Katayama, M | 2 |
| Uzuka, Y | 1 |
| Yabe, K | 1 |
| Takasuna, K | 1 |
| Satoh, H | 3 |
| Furuhama, K | 4 |
| Eng, J | 1 |
| Wilson, RF | 1 |
| Subramaniam, RM | 1 |
| Zhang, A | 1 |
| Suarez-Cuervo, C | 1 |
| Turban, S | 1 |
| Choi, MJ | 1 |
| Sherrod, C | 1 |
| Hutfless, S | 1 |
| Iyoha, EE | 1 |
| Bass, EB | 1 |
| Tong, GE | 1 |
| Kumar, S | 1 |
| Chong, KC | 1 |
| Shah, N | 1 |
| Wong, MJ | 1 |
| Zimmet, JM | 2 |
| Wang, ZJ | 2 |
| Yee, J | 2 |
| Fu, Y | 2 |
| Yeh, BM | 2 |
| Fananapazir, G | 1 |
| Troppmann, C | 1 |
| Corwin, MT | 1 |
| Bent, CK | 1 |
| Vu, CT | 1 |
| Lamba, R | 1 |
| Langner, S | 1 |
| Stumpe, S | 1 |
| Kirsch, M | 2 |
| Petrik, M | 2 |
| Hosten, N | 2 |
| Criado, E | 1 |
| Kabbani, L | 1 |
| Cho, K | 1 |
| El-Hajjar, M | 1 |
| Bashir, I | 1 |
| Khan, M | 1 |
| Min, J | 1 |
| Torosoff, M | 1 |
| DeLago, A | 1 |
| Juergens, CP | 1 |
| Winter, JP | 1 |
| Nguyen-Do, P | 1 |
| Lo, S | 1 |
| French, JK | 1 |
| Hallani, H | 1 |
| Fernandes, C | 1 |
| Jepson, N | 1 |
| Leung, DY | 1 |
| Thomsen, HS | 2 |
| Morcos, SK | 1 |
| Nie, B | 1 |
| Cheng, WJ | 1 |
| Li, YF | 1 |
| Cao, Z | 1 |
| Yang, Q | 1 |
| Zhao, YX | 1 |
| Guo, YH | 1 |
| Zhou, YJ | 1 |
| Heng, AE | 1 |
| Cellarier, E | 1 |
| Aublet-Cuvelier, B | 1 |
| Decalf, V | 1 |
| Motreff, P | 1 |
| Marcaggi, X | 1 |
| Deteix, P | 1 |
| Souweine, B | 1 |
| Jost, G | 1 |
| Pietsch, H | 1 |
| Sommer, J | 1 |
| Sandner, P | 1 |
| Lengsfeld, P | 1 |
| Seidensticker, P | 1 |
| Lehr, S | 1 |
| Hütter, J | 1 |
| Sieber, MA | 1 |
| Shakourirad, A | 1 |
| Ataeefar, M | 1 |
| Jozaghi, S | 1 |
| Bruce, RJ | 1 |
| Djamali, A | 1 |
| Shinki, K | 1 |
| Michel, SJ | 1 |
| Fine, JP | 1 |
| Pozniak, MA | 1 |
| Sendeski, M | 2 |
| Patzak, A | 2 |
| Pallone, TL | 1 |
| Cao, C | 1 |
| Persson, AE | 1 |
| Persson, PB | 3 |
| Cohen, MD | 1 |
| Nikolsky, E | 1 |
| Kirtane, AJ | 1 |
| Caixeta, A | 1 |
| Wong, SC | 1 |
| Teirstein, PS | 1 |
| Downey, WE | 1 |
| Batchelor, WB | 1 |
| Casterella, PJ | 1 |
| Kim, YH | 1 |
| Fahy, M | 1 |
| Dangas, GD | 1 |
| Staniloae, CS | 2 |
| Doucet, S | 2 |
| Sharma, SK | 3 |
| Katholi, RE | 3 |
| Mody, KR | 1 |
| Coppola, JT | 1 |
| Rajani, R | 1 |
| Haworth, P | 1 |
| Hildick-Smith, D | 1 |
| Reed, M | 1 |
| Meier, P | 1 |
| Tamhane, UU | 1 |
| Welch, KB | 1 |
| Moscucci, M | 1 |
| Gurm, HS | 1 |
| Nietlispach, F | 1 |
| Leipsic, J | 1 |
| Al-Bugami, S | 1 |
| Masson, JB | 1 |
| Carere, RG | 1 |
| Webb, JG | 1 |
| Cantor, E | 1 |
| Lim, L | 1 |
| Alexopoulos, E | 1 |
| Spargias, K | 1 |
| Kyrzopoulos, S | 1 |
| Manginas, A | 1 |
| Pavlides, G | 1 |
| Voudris, V | 1 |
| Lerakis, S | 1 |
| McLean, DS | 1 |
| Cokkinos, DV | 1 |
| Wessely, R | 1 |
| Koppara, T | 1 |
| Bradaric, C | 1 |
| Vorpahl, M | 1 |
| Braun, S | 1 |
| Schulz, S | 1 |
| Mehilli, J | 1 |
| Schömig, A | 1 |
| Kastrati, A | 1 |
| Hernández, F | 1 |
| Mora, L | 1 |
| Gómez-Blázquez, I | 1 |
| Bastante, T | 1 |
| Andreu, J | 1 |
| Recio-Mayoral, A | 1 |
| Lencioni, R | 1 |
| Fattori, R | 1 |
| Stacul, F | 2 |
| Matejka, J | 1 |
| Varvarovsky, I | 1 |
| Vojtisek, P | 1 |
| Herman, A | 1 |
| Rozsival, V | 1 |
| Borkova, V | 1 |
| Kvasnicka, J | 1 |
| Hu, S | 2 |
| Akhlaghi, F | 1 |
| Chitnis, S | 1 |
| Chiu, R | 1 |
| Go, S | 1 |
| Rout, P | 1 |
| Steffes, M | 1 |
| Abbott, JD | 1 |
| Dworkin, L | 1 |
| Bostom, A | 1 |
| Katayama, R | 2 |
| Watanabe, K | 1 |
| Yamagishi, N | 2 |
| Abe, S | 2 |
| Chou, SH | 1 |
| Kuo, J | 1 |
| Cabarrus, M | 1 |
| Aslam, R | 1 |
| Shunk, K | 1 |
| Elicker, B | 1 |
| Serafin, Z | 1 |
| Karolkiewicz, M | 1 |
| Gruszka, M | 1 |
| Strózecki, P | 1 |
| Lasek, W | 1 |
| Odrowaz-Sypniewska, G | 1 |
| Manitius, J | 1 |
| Beuth, W | 1 |
| Pahade, JK | 1 |
| LeBedis, CA | 1 |
| Raptopoulos, VD | 1 |
| Avigan, DE | 1 |
| Yam, CS | 1 |
| Kruskal, JB | 1 |
| Pedrosa, I | 1 |
| Briguori, C | 3 |
| Visconti, G | 1 |
| Ricciardelli, B | 3 |
| Condorelli, G | 1 |
| Shin, DH | 1 |
| Choi, DJ | 1 |
| Youn, TJ | 2 |
| Yoon, CH | 1 |
| Suh, JW | 1 |
| Kim, KI | 1 |
| Cho, YS | 1 |
| Cho, GY | 1 |
| Chae, IH | 1 |
| Kim, CH | 1 |
| Kato, M | 2 |
| Saito, J | 2 |
| Ladwig, M | 1 |
| Flemming, B | 1 |
| Seeliger, E | 1 |
| Sargsyan, L | 1 |
| Zo'o, M | 1 |
| Hoermann, M | 1 |
| Balassy, C | 1 |
| Brunelle, F | 1 |
| Azoulay, R | 1 |
| Pariente, D | 1 |
| Panuel, M | 1 |
| Le Dosseur, P | 1 |
| Kim, SJ | 1 |
| Choi, D | 1 |
| Ko, YG | 1 |
| Kim, JS | 1 |
| Han, SH | 1 |
| Kim, BK | 1 |
| Kang, SW | 1 |
| Hong, MK | 1 |
| Jang, Y | 1 |
| Choi, KH | 1 |
| Yoo, TH | 1 |
| Schönefeld, E | 1 |
| Höwler, S | 1 |
| Osada, N | 1 |
| Torsello, G | 1 |
| Du, H | 1 |
| Papadopoulou-Rosenzweig, M | 1 |
| Carbray, J | 1 |
| Yamashita, T | 1 |
| Franke, RP | 1 |
| Jung, F | 1 |
| Chen, Y | 1 |
| Liu, Y | 1 |
| Zhao, R | 1 |
| Fu, G | 1 |
| He, Q | 1 |
| Su, X | 1 |
| Zheng, Y | 1 |
| Qi, X | 1 |
| Liu, H | 1 |
| Wang, J | 1 |
| Gao, W | 1 |
| Liu, S | 1 |
| Zheng, X | 1 |
| He, B | 1 |
| Yang, P | 1 |
| Zhou, S | 1 |
| Gao, C | 1 |
| Qiu, C | 1 |
| Semerci, T | 1 |
| Cuhadar, S | 1 |
| Akçay, FA | 1 |
| Aydin, TK | 1 |
| Atay, A | 1 |
| Köseoglu, M | 1 |
| Bayata, S | 1 |
| Davenport, MS | 1 |
| Khalatbari, S | 1 |
| Dillman, JR | 1 |
| Cohan, RH | 1 |
| Caoili, EM | 1 |
| Ellis, JH | 1 |
| Aspelin, P | 3 |
| Aubry, P | 2 |
| Fransson, SG | 2 |
| Strasser, R | 2 |
| Willenbrock, R | 2 |
| Berg, KJ | 2 |
| Sandler, CM | 1 |
| Gruber, SJ | 1 |
| Shapiro, CJ | 1 |
| Braun, C | 1 |
| Birck, R | 1 |
| Sergeev, PV | 1 |
| Poliaev, IuA | 1 |
| Shimanovskiĭ, NL | 1 |
| Erdogan, A | 1 |
| Davidson, CJ | 1 |
| Lundkvist, J | 1 |
| Kini, A | 1 |
| Weigel, C | 1 |
| Colombo, A | 2 |
| Airoldi, F | 2 |
| Melzi, G | 1 |
| Michev, I | 2 |
| Carlino, M | 2 |
| Montorfano, M | 2 |
| Chieffo, A | 1 |
| Bellanca, R | 1 |
| Deray, G | 1 |
| Blondin, D | 1 |
| Hetzel, GR | 1 |
| Jung, G | 1 |
| Schachner, T | 1 |
| Bonatti, J | 1 |
| Bonaros, N | 1 |
| Poeltl, R | 1 |
| Feuchtner, G | 1 |
| Laufer, G | 1 |
| Pachinger, O | 1 |
| Friedrich, G | 1 |
| Rosovsky, M | 1 |
| Rusinek, H | 1 |
| McCullough, PA | 2 |
| Bertrand, ME | 1 |
| Brinker, JA | 1 |
| Barrett, BJ | 1 |
| Katzberg, RW | 1 |
| Chen, N | 1 |
| Sahani, D | 1 |
| Soulez, G | 2 |
| Heiken, JP | 2 |
| Lepanto, L | 2 |
| Ni, ZH | 2 |
| Nelson, R | 1 |
| Feldkamp, T | 1 |
| Baumgart, D | 1 |
| Elsner, M | 1 |
| Herget-Rosenthal, S | 1 |
| Pietruck, F | 1 |
| Erbel, R | 1 |
| Philipp, T | 1 |
| Kribben, A | 1 |
| D'Andrea, D | 1 |
| Bonizzoni, E | 1 |
| Morici, N | 1 |
| Focaccio, A | 1 |
| Cosgrave, J | 1 |
| Sandstede, JJ | 1 |
| Roth, A | 1 |
| Machann, W | 1 |
| Kaupert, C | 1 |
| Hahn, D | 1 |
| Detrenis, S | 1 |
| Meschi, M | 1 |
| Savazzi, G | 1 |
| Solomon, RJ | 1 |
| Natarajan, MK | 1 |
| Gelormini, JL | 1 |
| Labinaz, M | 1 |
| Moreyra, AE | 1 |
| Nyman, U | 1 |
| Elmståhl, B | 1 |
| Leander, P | 1 |
| Coca, SG | 1 |
| Perazella, MA | 1 |
| Reed, PS | 1 |
| Dixon, SR | 1 |
| Boura, JA | 1 |
| O'Neill, WW | 1 |
| Kahn, JK | 1 |
| Sahani, DV | 1 |
| Chen, KM | 1 |
| Xu, JR | 1 |
| Nelson, RC | 1 |
| Grazioli, L | 1 |
| Vanzulli, A | 1 |
| Kane, GC | 1 |
| Doyle, BJ | 1 |
| Lerman, A | 1 |
| Barsness, GW | 1 |
| Best, PJ | 1 |
| Rihal, CS | 1 |
| Locatelli, F | 1 |
| Anselmino, M | 1 |
| Biondi-Zoccai, G | 1 |
| Sheiban, I | 1 |
| Weisbord, SD | 1 |
| Hartwig, KC | 1 |
| Sonel, AF | 1 |
| Fine, MJ | 1 |
| Palevsky, P | 1 |
| From, AM | 1 |
| Bartholmai, BJ | 1 |
| Williams, AW | 1 |
| McDonald, FS | 1 |
| Jo, SH | 1 |
| Koo, BK | 1 |
| Kim, HS | 1 |
| Nguyen, SA | 1 |
| Suranyi, P | 1 |
| Ravenel, JG | 1 |
| Randall, PK | 1 |
| Romano, PB | 1 |
| Strom, KA | 1 |
| Costello, P | 1 |
| Schoepf, UJ | 1 |
| Kjaersgaard, P | 1 |
| Jakobsen, JA | 1 |
| Nossen, JO | 1 |
| Chalmers, N | 1 |
| Jackson, RW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.[NCT05147831] | 300 participants (Anticipated) | Interventional | 2021-11-30 | Recruiting | |||
| C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm[NCT03377049] | Phase 4 | 11 participants (Actual) | Interventional | 2019-07-28 | Completed | ||
| Prospective, Randomized, Comparative Study to Evaluate the Effect of Iodixanol 320 Compared to Iomeprol 350 on Contrast Medium Induced Nephropathy in Patients With Impaired Renal Function Undergoing PCI[NCT00390585] | Phase 4 | 324 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| Periprocedural Administration of Folic Acid for Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary CTA/Angiography/Angioplasty[NCT02444013] | Phase 4 | 400 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| Department of Geriatrics[NCT02575092] | Phase 2/Phase 3 | 4,000 participants (Actual) | Interventional | 2015-11-01 | Completed | ||
| Chinese People's Liberation Army General Hospital[NCT02718521] | 400 participants (Anticipated) | Interventional | 2016-03-31 | Active, not recruiting | |||
| A Randomized, Double-blinded Comparison of Iopromide and Iodixanol in Renally Impaired Patients Undergoing Cardiac Catheterization[NCT00926562] | Phase 4 | 592 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| A Single Center Observational Study- Incidence and Risk Factors of Acute Kidney Injury After Intravenous Contrast Enhanced Computed Tomography Scans[NCT04606056] | 5,000 participants (Anticipated) | Observational | 2020-05-31 | Recruiting | |||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer[NCT03943966] | 73 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| The Prevention Contrast-Induced Acute Kidney Injury With the Triple Combination of Hydration With Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate[NCT01210456] | Phase 3 | 458 participants (Anticipated) | Interventional | 2009-10-31 | Enrolling by invitation | ||
| BIcarbonato di Sodio e N-Acetilcisteina Nella Prevenzione Della Nefropatia da Mezzo di Contrasto Nell'infaRto mIocardico acutO(Registro BINARIO)[NCT01218178] | 520 participants (Actual) | Observational | 2008-06-30 | Completed | |||
| The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease[NCT00498342] | 0 participants | Interventional | 2007-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical neurological deterioration not attributable to other causes, mores specifically not due to re-bleeding, hydrocephalus, or metabolic changes. (NCT03377049)
Timeframe: Day 1-14 during the hospitalization
| Intervention | Participants (Count of Participants) |
|---|---|
| Acetazolamide Challenge | 2 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 19.785 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 21.659 |
The data that will be statistically compared is the pre-diamox perfusion in comparison to the post-diamox perfusion. A statistically significant change increase in CBF represents an appropriate response to Diamox. Lack of change in CBF or decrease in CBF could be suggestive of potential for developing vasospasm. (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 20.722 |
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
10 reviews available for iodixanol and Kidney Diseases
| Article | Year |
|---|---|
Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
Topics: Contrast Media; Creatinine; Female; Humans; Iohexol; Kidney Diseases; Male; Renal Insufficiency; Ret | 2022 |
Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials.
Topics: Contrast Media; Diabetes Complications; Humans; Kidney Diseases; Odds Ratio; Osmolar Concentration; | 2018 |
Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Topics: Contrast Media; Coronary Angiography; Creatinine; Humans; Iohexol; Kidney Diseases; Percutaneous Cor | 2018 |
Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Topics: Contrast Media; Evidence-Based Medicine; Humans; Incidence; Kidney Diseases; Osmolar Concentration; | 2016 |
The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Consumer Product Safety; Contrast Media; Evidence-Based Medicine; Female; H | 2009 |
Contrast-induced nephropathy-choice of contrast agents to reduce renal risk.
Topics: Contrast Media; Humans; Iopamidol; Kidney Diseases; Kidney Function Tests; Osmolar Concentration; Ri | 2009 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials.
Topics: Contrast Media; Humans; Iohexol; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; | 2005 |
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
Topics: Contrast Media; Creatinine; Diabetes Mellitus; Humans; Kidney Diseases; Osmolar Concentration; Rando | 2006 |
Renal safety of iodixanol.
Topics: Contrast Media; Humans; Kidney Diseases; Osmolar Concentration; Risk; Triiodobenzoic Acids | 2006 |
32 trials available for iodixanol and Kidney Diseases
| Article | Year |
|---|---|
Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Humans; Ioxaglic Acid; Kidney Diseases; Risk | 2023 |
Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; China; Contrast Media; Coronary Angiography; Double-Blind Met | 2017 |
Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Italy; | 2018 |
Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
Topics: Aged; Contrast Media; Creatinine; Female; Fluid Therapy; Humans; Intraoperative Care; Isotonic Solut | 2015 |
No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
Topics: Aged; Brain; Brain Ischemia; Contrast Media; Female; Humans; Ions; Kidney Diseases; Male; Osmolar Co | 2008 |
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon; Contrast Media; Coronary Angiography; Creatinine; Double | 2009 |
Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
Topics: Aged; Contrast Media; Dimerization; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Iopa | 2009 |
A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Contrast Media; | 2008 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; D | 2008 |
Assessment of the effect of radio contrast media on resistive index of renal artery by color doppler sonography.
Topics: Adult; Contrast Media; Female; Humans; Iohexol; Kidney Diseases; Male; Renal Artery; Triiodobenzoic | 2009 |
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic rena
Topics: Aged; Angioplasty, Balloon; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinin | 2009 |
Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Topics: Acute Disease; Aged; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Humans; Iopami | 2010 |
Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Medi | 2009 |
Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarker | 2010 |
High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Diabetes Complications; Double- | 2011 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Creatinine; Double-Blind | 2011 |
Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Double-Blind Method; Female; Humans; Infant; Io | 2011 |
[Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Contrast Media; Cost-Benefit Analysis; C | 2011 |
Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose.
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Kidney Diseases; Magnetic Resonance Imagi | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Topics: Aged; Biomarkers; Cardiac Catheterization; China; Contrast Media; Coronary Angiography; Coronary Art | 2012 |
Comparing the renal safety of isoosmolar versus low-osmolar contrast medium by renal biomarkers N-acetyl-β-D-glucosaminidase and endothelin.
Topics: Acetylglucosaminidase; Biomarkers; Blood Urea Nitrogen; Contrast Media; Creatinine; Endothelins; Fem | 2014 |
Nephrotoxic effects in high-risk patients undergoing angiography.
Topics: Aged; Angiography; Contrast Media; Creatinine; Diabetes Mellitus; Double-Blind Method; Female; Human | 2003 |
Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Coronary Angiography; Cost-Benefit Analysis; Healt | 2005 |
Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Double-Blind Method; Female; Humans; Iopamidol; Kidney | 2006 |
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Topics: Acetylglucosaminidase; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Do | 2006 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Topics: Acetylcysteine; Administration, Oral; Aged; Ascorbic Acid; Cardiovascular Diseases; Contrast Media; | 2007 |
Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Cardiac Catheterization; Chronic Disease; Contrast Media; Creatinine; Doubl | 2007 |
A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
Topics: Aged; Aorta, Abdominal; Contrast Media; Double-Blind Method; Drug-Related Side Effects and Adverse R | 2007 |
Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Female; Glomerular Filtratio | 2008 |
Determination of glomerular filtration rate with Visipaque in patients with severely reduced renal function.
Topics: Adult; Aged; Contrast Media; Glomerular Filtration Rate; Humans; Iodine; Iohexol; Iothalamic Acid; K | 1996 |
Comparison of iodixanol and iohexol in renal impairment.
Topics: Aged; Contrast Media; Creatinine; Female; Humans; Iohexol; Kidney; Kidney Diseases; Male; Middle Age | 1999 |
56 other studies available for iodixanol and Kidney Diseases
| Article | Year |
|---|---|
Magnetic iodixanol - a novel contrast agent and its early characterization.
Topics: Chemokine CCL2; Cineradiography; Contrast Media; Drug Compounding; Drug Evaluation, Preclinical; Dyn | 2018 |
CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Topics: Aged; Biomarkers; Blood Pressure; China; Chronic Disease; Contrast Media; Coronary Angiography; Coro | 2019 |
Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function.
Topics: Adult; Aged; Contrast Media; Creatinine; Female; Glomerular Filtration Rate; Humans; Injections, Int | 2013 |
Economic evaluation of intravenous iodinated contrast media in Italy.
Topics: Aged; Consumer Product Safety; Contrast Media; Cost-Benefit Analysis; Female; Humans; Infusions, Int | 2014 |
Effect of iodinated contrast medium in diabetic rat kidneys as evaluated by blood-oxygenation-level-dependent magnetic resonance imaging and urinary neutrophil gelatinase-associated lipocalin.
Topics: Acute-Phase Proteins; Animals; Contrast Media; Diabetes Mellitus, Experimental; Disease Models, Anim | 2015 |
Estimation of glomerular filtration rate in dogs by a single-blood sample method involving iodixanol.
Topics: Animals; Case-Control Studies; Chromatography, High Pressure Liquid; Contrast Media; Dogs; Glomerula | 2015 |
Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Contrast Media; Creatinine; Female; Glomeru | 2016 |
Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiography; Contrast Media; Creatinine; Female; Graft R | 2016 |
Catheter-less angiography for endovascular aortic aneurysm repair: a new application of carbon dioxide as a contrast agent.
Topics: Aged; Angiography, Digital Subtraction; Aorta; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel | 2008 |
Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
Topics: Acetylcysteine; Aged; Angiography; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; | 2008 |
Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
Topics: Animals; Cell Adhesion Molecules; Contrast Media; Dose-Response Relationship, Drug; Heme Oxygenase ( | 2009 |
Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
Topics: Analysis of Variance; Contrast Media; Creatinine; Female; Glomerular Filtration Rate; Humans; Incide | 2009 |
Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.
Topics: Analysis of Variance; Angiotensin II; Animals; Contrast Media; Endothelium, Vascular; Kidney Disease | 2009 |
Is the use of intravenous contrast material truly safe in patients with impaired renal function?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Creatinine; Female; Glomerular Filtratio | 2009 |
N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Topics: Acetylcysteine; Aged; Buffers; Coronary Angiography; Creatinine; Female; Free Radical Scavengers; Gl | 2009 |
The incidence of nephropathy in patients undergoing transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Cardiac Catheterization; Contrast Media; Glomerular Filtration Rate; Heart Va | 2009 |
CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement.
Topics: Aged; Aorta; Aortic Valve; Catheterization, Peripheral; Contrast Media; Femoral Artery; Heart Valve | 2009 |
The relative renal safety of iodixanol compared with low-osmolar contrast media.
Topics: Acute Disease; Contrast Media; Evidence-Based Medicine; Humans; Kidney Diseases; Meta-Analysis as To | 2009 |
Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creati | 2009 |
Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Topics: Chronic Disease; Contrast Media; Coronary Angiography; Diabetic Nephropathies; Humans; Inpatients; I | 2010 |
Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents.
Topics: Analysis of Variance; Angiotensin II; Animals; Contrast Media; Diatrizoate; Humans; Iohexol; Ioxagli | 2010 |
[Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?].
Topics: Contrast Media; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Triiodobenzoic Acids | 2010 |
Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Glomerular Filtrati | 2010 |
Comparison of plasma clearance of iodixanol during versus after angiography.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Coronary Angiography; Female; Glomerular Filtration Ra | 2010 |
Sequential measurements of glomerular filtration rate in conscious rats by a bolus injection of iodixanol and a single blood sample.
Topics: Aging; Animal Use Alternatives; Animals; Chromatography, High Pressure Liquid; Contrast Media; Glome | 2011 |
Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Contrast Media; Creatinine; Female; Humans; Injections, | 2011 |
Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Female; Humans; Incidence; Kidney Di | 2011 |
Optimum conditions for serum clearance of iodixanol, applicable to the estimation of glomerular filtration rate in horses.
Topics: Animals; Chromatography, High Pressure Liquid; Contrast Media; Female; Glomerular Filtration Rate; H | 2011 |
Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
Topics: Analysis of Variance; Animals; Bicarbonates; Contrast Media; Dose-Response Relationship, Drug; Glome | 2011 |
Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studie | 2011 |
Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studie | 2011 |
Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studie | 2011 |
Relation of homocysteinemia to contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studie | 2011 |
Simplified procedure for the estimation of glomerular filtration rate following intravenous administration of iodixanol in cats.
Topics: Administration, Intravenous; Animals; Blood Urea Nitrogen; Cat Diseases; Cats; Chromatography, High | 2012 |
Pathophysiology of the contrast media-induced nephropathy (CIN) in patients undergoing coronary interventions.
Topics: Animals; Contrast Media; Coronary Angiography; Humans; Iohexol; Kidney; Kidney Diseases; Kidney Fail | 2013 |
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Humans; | 2013 |
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Humans; | 2013 |
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Humans; | 2013 |
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Humans; | 2013 |
Contrast-agent-induced acute renal dysfunction--is iodixanol the answer?
Topics: Contrast Media; Diabetes Mellitus; Humans; Iohexol; Kidney; Kidney Diseases; Triiodobenzoic Acids | 2003 |
Nephropathy induced by contrast medium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Confounding Factors, Epidemiologic; Contrast Media; Creati | 2003 |
Nephropathy induced by contrast medium.
Topics: Contrast Media; Creatinine; Diabetes Complications; Fluid Therapy; Humans; Kidney; Kidney Diseases; | 2003 |
[Reduced risk of nepropathy with isoosmolar contrast media].
Topics: Angiography; Contrast Media; Humans; Iohexol; Kidney; Kidney Diseases; Risk Factors; Triiodobenzoic | 2003 |
[Lowering of nephropathy risk during angiography procedure. What are choice criteria for the radiocontrast media?].
Topics: Aged; Angiography; Contrast Media; Health Status; Humans; Intraoperative Complications; Iohexol; Kid | 2003 |
Recent clinical trials of iodixanol.
Topics: Clinical Trials as Topic; Confidence Intervals; Contrast Media; Diabetes Complications; Humans; Kidn | 2003 |
[No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
Topics: Aged; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Creatinine; | 2005 |
Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.
Topics: Aged; Chi-Square Distribution; Contrast Media; Coronary Angiography; Creatinine; Female; Gadolinium | 2006 |
Iodixanol and chronic kidney disease.
Topics: Chronic Disease; Contrast Media; Diabetic Nephropathies; Humans; Kidney Diseases; Triiodobenzoic Aci | 2006 |
[Angiographic picture of severe acute renal microangiopathy].
Topics: Acute Disease; Adult; Angiography, Digital Subtraction; Biopsy; Contrast Media; Diagnosis, Different | 2006 |
Risk factors of postoperative nephropathy in patients undergoing innovative CABG and intraoperative graft angiography.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Artery B | 2006 |
Dose-related nephrotoxicity.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carotid Artery Diseases; Contrast Media; Female; Humans | 2006 |
Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Topics: Adult; Aged; Carcinoma; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Esophageal Neoplasms; | 2007 |
Contrast nephropathy: isosmolar and low-osmolar contrast media.
Topics: Contrast Media; Humans; Kidney Diseases; Meta-Analysis as Topic; Osmolar Concentration; Triiodobenzo | 2007 |
Suggesting gadolinium-based contrast media for CT in azotemic patients is not based on historical, clinical, and experimental data.
Topics: Animals; Azotemia; Contrast Media; Gadolinium DTPA; Humans; Kidney Diseases; Mice; Tomography, X-Ray | 2007 |
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltration.
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Hemofiltration; Humans; Kidney D | 2007 |
Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Topics: Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Coronary Angiography; Female; Gadolinium D | 2007 |
Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Topics: Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Dose-Response Relationship | 2008 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Acetylcysteine; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiography; Creatinine | 2008 |
Letter regarding article by Solomon et al, "Cardiac Angiography in REnally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease".
Topics: Angioplasty, Balloon, Coronary; Confounding Factors, Epidemiologic; Contrast Media; Coronary Angiogr | 2008 |
The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Topics: Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Humans; | 2008 |
Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
Topics: Aged; Angiography; Case-Control Studies; Chi-Square Distribution; Contrast Media; Creatinine; Female | 2008 |
Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
Topics: Angiography; Contrast Media; Cystatin C; Cystatins; Glomerular Filtration Rate; Humans; Iohexol; Iox | 2008 |